Grazia Equity is a venture Capital firm investing in innovative, technology driven startups with high potential. Based in Stuttgart (Germany), Grazia has been supporting a large number of mostly young companies, often from their foundation to the Initial Public Offering or eventual sale. In contrast to other venture capital firms, they predominantly work with their own capital that they invest as entrepreneurs.

Grazia Equity

Alpana Ventures is a Swiss VC focusing on digital transformation. Since 2016 we backed 45 founder teams with 3 Funds, supporting them in their journey towards a positive impact. Committed to value creation, we discover deep tech solutions in Switzerland, Europe and the US. We invest to embed them into innovative business models and back them to become global market leaders. Applying ESG criteria, our portfolio companies help create a more sustainable future.

Alpana Ventures

Plug and Play is a seed and early-stage investor focused on great teams leading emerging growth companies.  Plug and Play runs 12 industry-specific accelerator programs twice a year, that acts as a platform for major corporations and high quality startups to connect and collaborate.  Located in the heart of Silicon Valley, Plug and Play participates in Seed, Angel and Series A funding where they often co-invest with their strategic partners. Through years of experience and as part of their network, Plug and Play has put together a world-class network of serial entrepreneurs, strategic investors, and industry leaders who actively assist the firm with its successful and growing investment portfolio.  SEED ROUND. Plug and Play participates in seed round investing through a program called Startup Camp. Startup Camp is a 10-week program based in Silicon Valley for top-notch entrepreneurs to work intensively on building out their business model. Select startups will refine their business models and prototypes with help from a combination of structured workshops, speaker series and mentorship sessions, as well as active coaching from their investment team. At the culmination of Startup Camp, founders will have crystalized their business plans and pitched their company to the venture capital community at EXPO Demo Day.''  ANGEL ROUND Plug and Play makes angel round investments throughout the year, sourced from their monthly Plug and Play Angels (PAPA) sessions. They are partnered with local angel investors in Silicon Valley who participate in PAPA to find the most promising startups and best new technologies.  SERIES A. Series A typical Series A round is in the range of $2 million to $10 million, and is intended to provide operating capital for the company for six months to two years. This round capitalizes the company as it develops its products, performs initial marketing and branding, acquires talent, and conducts other early-stage business operations. It is in this stage that Plug and Play will co-invest with over 180 venture capital partners.  Plug and Play has helped grow market leaders such as PayPal, Danger, Google, DropBox, LendingClub, Zoosk, SoundHound, CreditSesame, Skytree, and has over 400 more early-stage startups in its portfolio.

Plug and Play

Social Starts is a venture capital firm with a data-driven approach to investing in moment-of-inception and Series A financing rounds. The firm prefers to invest in early-stage companies operating in the technology, health tech, internet, and mobile tech sectors.

Social Starts

Wessel Management GmbH is the vehicle for venture capital and other investments made by the family of Rolf Christof Dienst. For 40 years, they have been investing directly (and through Rolf, founding partner of Wellington Partners, also indirectly) with entrepreneurs, who show the greatest potential to achieve success for interesting ideas and/or technologies. They particularly like to engage with companies, which contribute to the wellbeing and prosperity of society in general. We mostly invest in conjunction with a small group of co-investors – all experienced entrepreneurs themselves with specific industry knowledge and wide-ranging personal networks. Together with these partners, they support our portfolio companies actively. They often engage at an early stage and their own investments typically range from 1% to 25% of a portfolio company’s share capital. While they love accompanying entrepreneurs on their journey to commercial success, human interactions and ethical aspects equally define their partnerships.

Wessel Management

ACME Capital is a venture capital and private equity firm that invests in breakthrough technologies that fuel platform shifts and disruptive business models that capitalize on new platforms. Its purpose is to support those founders who choose to take their capital.  The firm was founded in 2018 and headquartered in San Francisco, California.

ACME Capital

Mayo Clinic, a not-for-profit medical group practice, provides medical care, research, and education services. It offers medical care services in various specialties, including diabetes and endocrinology, gastroenterology, gynecology, cancer, neurology and neurosurgery, orthopedics, pulmonology, rheumatology, nephrology, urology, and cardiology and heart surgery.

Mayo Clinic

Everpreneur Capital

Techstars is a global platform that provides investment and innovation. Through the Techstars Worldwide Entrepreneur Network, founders and their teams connect with other entrepreneurs, experts, mentors, alumni, investors, community leaders, and corporate partners who will help their companies grow. Techstars operates four divisions: Techstars Mentorship-Driven Accelerator Program supercharges success and Techstars Startup Programs inspire, educate, and connect entrepreneurs. Techstars Venture Capital Fund invests in innovative and disruptive companies. Techstars Corporate Innovation Partnerships help brands create products and services. Techstars' accelerator portfolio includes more than 1,000 companies with a market cap of $8.1 billion.

Techstars

The Cedars-Sinai Accelerator is transforming healthcare quality, efficiency, and care delivery by helping entrepreneurs bring their innovative technology products to market.     This three-month program, based in Los Angeles, California, provides companies with $100,000 in funding, mentorship from more than 300 leading clinicians and executives, access to Cedars-Sinai, and exposure to a broad network of entrepreneurs and investors. Since 2015, the accelerator has helped dozens of companies transform healthcare delivery and patient care. It helps technology innovators turn their ideas into breakthroughs that can improve the lives of patients around the world.

Cedars-Sinai Accelerator

Wing Venture Capital primarily invests in technology-based businesses. It emphasizes craftsmanship over volume and engages deeply with founders to help them build companies that matter. The body of work of Wing's team spans more than two decades and dozens of successful early-stage companies, 21 of which went on to achieve billion-dollar-plus outcomes following IPOs or acquisitions. Its portfolio companies include Cohesity, Gong, Instart Logic, Juvo, Moogsoft, Palerra, Shape Security, and Snowflake.

Wing Venture Capital

Techstars Ventures (formerly Bullet Time Ventures) is the venture capital arm of Techstars. Bullet Time Ventures is a $150 million fund based in Boulder, Colorado.

Techstars Ventures

Intermountain Ventures is the strategic investment arm of Intermountain Healthcare. It focuses on new ventures, strategic investing, and strategic partnerships. It partners with early- and growth-stage companies, corporations, venture capital/private equity firms, technology organizations, and mission-based organizations that are leading the charge to improve health. It was founded in 2019 and is based in Salt Lake City, Utah.

Intermountain Ventures

GYANT

GYANT is a digital front door solution for health systems that uses AI to navigate patients to the right care setting and relevant in-network resources. GYANT helps health systems implement digital patient journeys to effectively capture new patients, efficiently serve existing ones, and drive process automation across the enterprise.

<div><p>GYANT is a 24/7 AI chatbot for triage and diagnosis. The chatbot asks patients a series of questions about symptoms which are interpreted using natural language processing to determine an appropriate course of action. The chatbot can also provide answers to queries, leave prescription refill requests, and direct patients to a telehealth or in-patient booking system.&nbsp;</p></div>

More important now than ever, telehealth will long outlast the pandemic that drove its growth.

Telehealth

<div><p>GYANT is a digital front door solution for health systems that uses AI to navigate patients to the right care setting and relevant in-network resources. GYANT helps health systems implement digital patient journeys to effectively capture new patients, efficiently serve existing ones, and drive process automation across the enterprise.</p></div>

Using AI to mimic and understand human language

Natural Language Processing Tools

Simplifying healthcare administration with intuitive tech tools

Hospital Management

Why Fabric Is Buying GYANT

<div>
  <p>
    GYANT is a 24/7 AI chatbot for triage and diagnosis. The chatbot asks patients a series of questions about symptoms which are interpreted using natural language processing to determine an appropriate course of action. The chatbot can also provide answers to queries, leave prescription refill requests, and direct patients to a telehealth or in-patient booking system.&nbsp;
  </p>
  <p>
    Founded in 2016, the company configures its solutions to integrate with a provider's digital tools, clinical endpoints, electronic health record systems, website, patient portal, branding, and mobile app.&nbsp;
  </p>
  <p>
    GYANT&rsquo;s customer base grew to 24 healthcare systems as of July 2020 compared to 9 in July 2019. In July 2020, Gyant raised a Series A funding round that brought total funding to USD 22.8 million.
  </p>
</div>


<div>
  <p>
    Nice Healthcare is a US based telehealth company with a focus on primary care services to business-to-business (B2B) clients. Once the employer signs its employees with Nice (at a cost of USD 30 to USD 36 per employee per month), employees do not have to incur out of pocket expenses for Nice services and can schedule virtual or home visits within the time frames specified by the company. It connects patients with practitioners through a mobile app over video calls or text messages. Members can also request home visits which will be completed within a few hours, as claimed by the company. As of March 2022, Nice was operating in twelve states, and had over 400 small and medium enterprises (SMEs).
  </p>
  <p>
    In March 2022, the company raised USD 30 million in Series A financing led by DNA Capital which has been earmarked to expand its platform&rsquo;s reach among small and medium businesses. Additionally, the company is hiring three members for its management team to support the continuing growth of the organization.
  </p>
  <p>
  </p>
</div>


Nice Healthcare

<p><span>Amicomed is a cloud-based Software-as-a-Service (SaaS) platform which provides blood pressure monitoring services. It collects blood pressure data of patients from at-home devices, applies algorithms, and assesses the fluctuations in the blood pressure. Physicians can be connected and provided with blood pressure data of their patients in order to facilitate their workload, enabling more personalized management of patients regarding medication and lifestyle indications.</span></p><p><span>Amicomed can also recommend actionable and personalized lifestyle interventions such as daily diet and exercises via virtual coaching.</span></p>

Amicomed

<p><span>Winston is a men’s health telemedicine platform that treats common issues impacting men such as sexual problems, hair loss, acne, and cold sores. Winston allows patients to consult doctors, place orders for prescription drugs, and offers free delivery to the homes of patients.</span></p><p><span>The Toronto-based company aims to avoid men deferring doctor visits or withholding sensitive information. The consultation fee is covered by the provincial health plan, but the prescriptions are billed to the customer.</span></p>

Winston

<p><span>Eko Health is a digital health company that has developed an AI-powered platform for detecting heart and lung diseases during routine physical examinations. The company's flagship product, SENSORA, comprises digital stethoscopes integrated with advanced algorithms that can identify structural heart murmurs, low ejection fraction (indicative of heart failure), and atrial fibrillation.</span></p>
<p><span>In June 2024, Eko Health raised USD 41 million in a Series D funding round to scale its disease detection platform globally. The company's murmur detection algorithm, cleared by the FDA, was clinically validated in a study at Massachusetts General Hospital, demonstrating a two-fold increase in identifying structural heart murmurs compared to standard practice. Furthermore, Eko's low ejection fraction algorithm, developed in collaboration with Mayo Clinic, significantly improved the detection of heart failure with reduced ejection fraction in a study conducted at Imperial College London.</span></p>
<p><span>Eko Health's technology aims to reduce diagnostic bottlenecks and enhance patient outcomes by facilitating early detection of cardiac and pulmonary diseases. With over 500,000 healthcare professionals utilizing its FDA-cleared platform worldwide as of June 2024, the company has established a substantial presence in the market.</span></p>
<p><span>In June 2023, Eko Health launched its next-generation digital stethoscope, CORE 500, featuring advanced capabilities such as a full-color display, 3-lead electrocardiogram (ECG), and TrueSound technology for optimal sound filtering. The CORE 500 received FDA 510(k) clearance and seamlessly integrates with the SENSORA platform.</span></p>
<p><b><strong>Key customers and partnerships</strong></b></p>
<p><span>In November 2023, Eko Health announced a large-scale deployment of its AI-enabled technology through the TRICORDER program, an implementation initiative led by Imperial College London and funded by the National Institute for Health and Care Research (NIHR). The program aims to deploy Eko's technology to 100 General Practitioner (GP) practices across the UK, assisting clinicians in evaluating heart failure, valvular heart disease, and atrial fibrillation.</span></p>
<p><span>Additionally, Eko Health has partnered with leading academic institutions such as Massachusetts General Hospital and Mayo Clinic to validate the clinical utility and positive impact of its technology on patient care.</span></p>
<p><br></p>

Eko Health

<div>
  <p>
    Dialogue partners with employers and health insurers to offer telehealth services to their employees and members. The users have 24/7 access to doctors, nurses, and other healthcare professionals via audio, video, and chat options for wide arrays of physical and mental health needs, artificial intelligence-enabled (AI-enabled) triage, referrals, and prescription renewals. 
  </p>
  <p>
    The company launched its trademarked Integrated Health Platform in January 2021 to consolidate its virtual care,  wellness programs, mental healthcare services, and Employee Assistance Program (EAP) onto a single platform. The company claims to be the only integrated health and wellness B2B platform in Canada. 
  </p>
  <p>
    <b>Key Customers and partnerships</b>
  </p>
  <p>
    Dialogue had direct relationships with over 2,000 customers across Canada and Germany as of December 2020 and served around 50,000 organizations through these partnerships. In addition, the number of members with access to the virtual platform topped 1 million in January 2021. 
  </p>
  <p>
    <b>Fundings and financials</b>
  </p>
  <p>
    As of March 2021, Dialogue was planning to raise CAD 100 million (USD 80 million) from an initial public offering that will be listed on the Toronto Stock Exchange under the ticker symbol &ldquo;CARE.&rdquo; 
  </p>
  <p>
    In Q2 2023, net losses reduced significantly YoY to CAD 5.8 million (USD 4.3 million) from CAD 8.4 million (USD 6.3 million) in Q2 2022. Top-line revenue met internal expectations, growing 17.2% YoY to CAD 25.5 million (USD 19.0 million), driven by &nbsp;an increase in new members (by 18.6% YoY), 
    an expansion of the attach rate as existing customers added more services, and full-quarter contributions from Tictrac.
     
    Dialogue Health has not provided any forward-looking guidance as the company has entered into an agreement to be 
    <a href="https://investors.dialogue.co/English/news/news-details/2023/Dialogue-to-be-Acquired-by-Sun-Life/default.aspx">
      <u>acquired by financial services company Sun Life Financial</u>
    </a>
     for a consideration of CAD 365 million (USD 270 million) or CAD 5.15 (USD 3.82) per share. The transaction is expected to close in Q4 2023. Post acquisition, Dialogue will delist from the Toronto Stock Exchange but will continue to operate as a standalone entity under the &ldquo;Sun Life Canada&rdquo; brand from its head office in Qu&eacute;bec. 
  </p>
  <p>
  </p>
</div>


Dialogue

Real-time collection of patients’ health-related data using any remote patient monitoring device combined with general telemedicine services to reduce readmission rates. 


A platform that facilitates the transmission of patient data to different locations for further evaluation and interpretation by medical specialists. 


A digital platform that offers specialty care services to address the specific needs of a patient or demographic, including consultations where patients are generally reluctant to meet practitioners face-to-face.

Primary care through virtual consultations for general health-related concerns using a digital platform or mobile app. 

Companies developing B2B software solutions for patient engagement, care navigation, practice management, and electronic health records integration to facilitate telehealth services for healthcare providers. 

IoT is used by most telehealth providers to operate virtual services

All telehealth players are involved in digital health via virtual offerings

Industry players offer varying degrees of personalization for each target audience

Some players offer technology and platforms to healthcare providers, converting physical-only services into virtual services

Specific telehealth offerings focus on diversity and inclusion, providing care to LGBTQ+ or BIPOC populations

Generative AI is used to streamline administrative tasks such as clinical note-taking

<div>
  <p>
    GYANT is a digital front door solution for health systems that uses AI to navigate patients to the right care setting and relevant in-network resources. GYANT helps health systems implement digital patient journeys to effectively capture new patients, efficiently serve existing ones, and drive process automation across the enterprise.
  </p>
</div>


<div>
  <p>
    Reduct is an AI-powered cloud video platform that aims to allow for richer human communication. The company is led by Prabhas Pokharel and Robert Ochshor, based in San Francisco.
  </p>
</div>


Reduct

<div>
  <p>
    MonkeyLearn provides a simple graphical interface where users can create customized text classification and extraction analysis by training machine learning models such as sentiment analysis, topic detection, keyword extraction, and more. MonkeyLearn can be integrated with hundreds of other applications through its direct integrations and open API.All of that without the need of roping in developers or data scientists.
  </p>
</div>


MonkeyLearn

<div>
  <p>
    Keatext will help you cultivate meaningful relationships with your customers by providing you with instant clarity on what they care about most, and by increasing your ability to respond rapidly to their needs by synthesizing large volumes of unstructured feedback data from multiple channels (such as open-survey questions, online reviews, chat logs and social media posts) to produce actionable insights delivered on one comprehensive custom dashboard.
  </p>
</div>


Keatext

<div>
  <p>
    Powerful in-meeting sales tools and intelligence.
  </p>
</div>


Aircover

<div>
  <p>
    NeuralSpace is a Software as a Service (SaaS) platform which offers developers a suite of APIs for Natural Language Processing (NLP) that you can use without having any Machine Learning (ML) or Data Science knowledge. Along with some of the common languages like English, German, French, etc., the platform supports various languages spoken acrossIndia, South East Asia, Africa, Middle East, Scandinavia and Eastern Europe, aka, low-resource languages. The primary goal is to democratize NLP and make sure any developer can create apps with advanced language processing in any language and not just English. The platform comes with various language processing Apps that can help you classify long or short text into categories, identify speakers in a given audio file, transcribe speech into text, and much more. The AI models that power our platform are state-of-the-art, quality assured and ready for you to customize or consume out-of-the-box. The NeuralSpace platform is designed as a no-code/low-code platform for you to go to market faster and focus on the business problems you are solving, while we take care of all your language processing needs.
  </p>
</div>


NeuralSpace

Solutions that use techniques such as named entity recognition, part-of-speech tagging, or summarization to produce insights from unstructured textual documents.

Platforms that summarize conversations, audio, or video files including reactions into text formats.

Tools to identify and analyze the opinions or emotions expressed in survey responses or reviews to produce actionable insights.

Platforms that decipher search queries by analyzing structured and unstructured data based on user intent and behavior.

Solutions that enable real-time conversation through chatbots or automate ticket routing to relevant agents.

Tools that automatically translate text from one language to another.

Tools that detect plagiarism, punctuation errors, or style errors in text.

NLP tools such as chatbots are used to cater to each individual

NLP tools are built using AI/ML technologies

Some NLP tools are built using foundation models

NLP tools are provided for other companies to integrate into their workflows

<div>
  <p>
    ModMed is transforming healthcare by placing doctors and patients at the center of care through an intelligent, specialty-specific cloud platform. Their specialty-specific, data-driven, and cloud-based electronic health records (EHR) and practice management (PM) systems, plus revenue cycle management (RCM) services, were built by a team including specialty physicians and practice management professionals.
  </p>
</div>


Modernizing Medicine

<div>
  <p>
    Kyruus delivers proven provider search and scheduling solutions that help hospitals and health systems match patients with the providers best suited to care for them. The ProviderMatch suite of solutions&mdash;for consumers, access centers, and referral networks&mdash;enables a consistent patient experience across multiple points of access, while aligning provider supply with patient demand. The company&rsquo;s proprietary provider data management platform forms the foundation of its solutions, powering them with accurate data by coupling data processing with administrative applications. Kyruus was founded in 2010 and is headquartered in Boston, Massachusetts.
  </p>
</div>


Kyruus

<div>
  <p>
    AKASA is an AI-powered automation company for revenue cycle management in healthcare. The company provides hospitals with Unified Automation services, which is a flexible AI-based solution that automates complex operational tasks such as those related to revenue cycle management. Its approach imbues the entire automation process with human judgment and subject matter expertise. Unified Automation operates within a hospital's existing electronic health record (EHR) and revenue cycle infrastructure to reduce errors and improve efficiencies.
  </p>
</div>


AKASA

<div>
  <p>
    XSOLIS is a healthcare technology firm focused on improving healthcare operations through cognitive computing. By aligning cognitive computing behind clinical expertise, we're creating a new framework for decision-making.
  </p>
</div>


XSOLIS

<div>
  <p>
    Suki is an AI-powered, voice-enabled digital assistant for doctors. It was designed to help healthcare organizations with their administrative tasks. Suki helps physicians in dictating notes, retrieving info, and working with EHR. The company was founded in 2017 and is headquartered in Redwood City, California.
  </p>
</div>


Suki

Platforms used by hospitals to manage the various aspects of patient care to improve overall efficiency, such as automating routine tasks, improving communication and coordination among healthcare providers, and enhancing patient outcomes within the hospital setting

Platforms that enable patients to actively participate in their healthcare journey by educating and engaging them, along with improving communication with healthcare providers

Platforms that help healthcare organizations analyze patient data and other performance metrics to improve decision-making and optimize resource allocation

Platforms that are designed to help hospitals and health systems manage their financial operations from patient billing and insurance claims to revenue tracking and analysis

AI-powered software solutions that are designed to help healthcare organizations streamline and automate the process of documenting patient encounters

IoT medical solutions turn traditional hospitals into smart hospitals, allowing them to streamline workflows

AI/ML algorithms optimize workflows, enable predictive modeling, and analyze patient data in healthcare

Offers software platforms that streamline and improve hospital operations

GYANT

EDGE Insights

About EDGE

Contact Us

Resources

Area of Focus

Technology Research Made Effortless